The number of 👥 in need in Burkina Faso, Northern Cameroon,Chad,Mali,Niger, and North-Eastern Nigeria 📈 from 24M in 2018 to over 30M in 2022 due to the combined effect of:
🚨 increasingly violent conflicts
🚨 deep poverty
🚨 climate change
🚨 unprecedented food insecurity
@OMS_Burkina@OMS_Afrique In #BurkinaFaso🇧🇫 WHO and partners worked to ensure that people in remote areas can access health services by setting up mobile clinics, rehabilitating health facilities and supporting #healthworkers.
In #Cameroon🇨🇲 WHO supported the Ministry of Health to respond not only to #COVID19 with three vaccination campaigns but also to outbreaks of other infectious diseases such as yellow fever and cholera.
WHO supported the installation of 17 laboratories in #Chad🇹🇩 to increase #COVID19 testing capacities and trained some 4,000 👩🏾⚕️🧑🏾⚕️ on COVID-19 surveillance, case management, and infection prevention and control.
In 2021 #Mali🇲🇱 faced outbreaks of cholera, measles and polio, in addition to #COVID19. WHO supported access to quality primary healthcare services, including in hard-to-reach areas, reaching more than 2.6M children, women, and men.
In 2021 #Niger🇳🇪 experienced the worst cholera outbreak in over a decade. WHO supported the country in surveillance, 🚰 risk communication, and community engagement.
1.9M people were vaccinated which helped to bring the outbreak under control by the end of 2021.
Overweight & #obesity are major risk factors for a number of chronic diseases, including:
🚨 type 2 diabetes
🚨 cardiovascular diseases
🚨 cancer
🚨 hypertension
🚨 stroke
🚨 mental health issues
WHO suggests that molnupiravir is only provided to non-severe COVID-19 patients with the highest risk of hospitalization - e.g. people who have not received a #COVID19 vaccination, older people, people with immunodeficiencies & people living with chronic diseases like diabetes
Children, pregnant and breastfeeding women should not be given the drug.
People who take molnupiravir should have a contraceptive plan. Health systems should ensure access to pregnancy testing and contraceptives at the point of care.
LIVE: Media briefing on expanding local pharmaceutical manufacturing with Dr Tedros twitter.com/i/broadcasts/1…
"Vaccines are among the most powerful inventions in human history. Thanks to vaccines, smallpox is no more, polio is on the brink of eradication, and once-feared diseases like diphtheria, tetanus, measles and meningitis can now be easily prevented"-@DrTedros#VaccinesWork
@DrTedros "And of course, vaccines have helped to change the course of the #COVID19 pandemic. But this scientific triumph has been undermined by vast inequities in access to these life-saving tools"-@DrTedros#VaccinEquity
@DrTedros "This week marks 1 year since #COVAX made its 1st delivery in Africa, to 🇬🇭. Unfortunately, 💉 nationalism & manufacturers prioritizing high-income countries in the 1st half of last year severely limited the number of 💉 COVAX was able to supply in the 1st half of 2021"-@DrTedros
@DrTedros "As a result, 83% of the population of Africa is yet to receive a single dose. This is not only a moral failure, it is also an epidemiological failure, which is creating the ideal conditions for new variants to emerge"-@DrTedros#PortsToArms
"We have been targeted with marketing from formula milk companies."
Over half of parents & pregnant women exposed to formula milk marketing, violating international standards and harming child health
-🆕 WHO, @UNICEF survey
Based on available data of transmission, severity, reinfection, diagnostics, therapeutics & impacts of vaccines, BA.2 sublineage of Omicron should continue to be considered a variant of concern and should remain classified as #COVID19 Omicron bit.ly/33GSg0I
Reinfection with #COVID19 Omicron BA.2 following infection with BA.1 has been documented, however, initial data from population-level reinfection studies suggest that infection with BA.1 provides strong protection against reinfection with BA.2 bit.ly/33GSg0I